Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

NRXPNRXP
Showing 8 of 9 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in NRX PHARMACEUTICALS INC

Yes. Geode Capital Management holds 314,659 shares of NRXP (NRX Pharmaceuticals), worth $1.3M, as of its Q2 2026 13F filing. It increased the position by 4,547 shares (+1.5%) from Q1 2026. Geode Capital Management has held NRXP since Q2 2024, across 9 quarterly 13F filings.

Current Value

$1.3M

Current Shares

314,659

Total Value Change

+$1.2M

Total Shares Change

+237,318

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
314,659
+1.5%
$1.3M0.0%$4.09
26
2026-Q1
Increased
310,112
+41.7%
$660,6090.0%$1.80
22
2025-Q4
Increased
218,866
+17.8%
$593,2120.0%$2.63
19
2025-Q3
Increased
185,862
+7.9%
$613,4550.0%$3.25
18
2025-Q2
Increased
172,255
+27.9%
$561,5960.0%$3.42
21
2025-Q1
Increased
134,657
+81.3%
$276,0810.0%$2.03
24
2024-Q4
Decreased
74,251
-4.0%
$163,3890.0%$1.53
0
2024-Q3
Increased
77,341
+17.8%
$130,7280.0%$1.75
18

Other major holders of NRXP: VANGUARD CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used